Ruti Aga and the Six-Year Ban: The Clinic Never Existed, the Prescription Did

A prescription. A clinic that does not appear in any medical registry. A signature from someone claiming to be a doctor, who turned out to be a family member with no medical registration. And one final detail, so small it is almost comic: that person claimed to have used an old prescription pad from a former workplace, while the workplace itself confirmed she had never worked there for a single day.

The Athletics Integrity Unit did not need a long investigation to peel that document apart. They only needed to make a verification call. And the answer, per the AIU statement, was: the clinic does not exist, the prescription is not ours, the signatory holds no practising registration.

Ruti Aga began serving a six-year ban on 10 September.

Six years. Not two years for a methylprednisolone positive. But two years, plus four years, served consecutively, not concurrently. I read that evidentiary chain several times — not because it is complex, but because it is too simple. So simple that someone believed a single sheet of paper would be enough to close a gap in their medical file.

And that is where this story really begins — not in a laboratory, but somewhere very different.

Context: the 32-year-old standing at the very top of the road

To understand the scale of the sanction, you have to understand who Aga was before that prescription existed.

She won the 2026 Tokyo Marathon — one of six races in the World Marathon Majors system, the highest tier of world road racing. She has three runner-up finishes at Major races. For an Ethiopian female marathoner, that is not the record of someone who had one lucky day; it is the trace of a decade of training inside a system of terrifying depth.

In March, she won a half marathon in China. The statement does not disclose the time from that race. I note this because it matters: without a number, any inference about the sporting significance of that win is speculation. But its economic significance needs no number — a half marathon inviting East African athletes to China, within an appearance-fee current that has existed for over a decade, is an event with money in it. A lot of money, by the standards of a track and field athlete.

She is 32. In women's marathon, 32 is not decline — it is ripeness. The peak window commonly extends to 35, even 36 or 37 for athletes with a good physical base and sensible load management. In other words, this sanction did not land as Aga was sliding. It landed precisely at the intersection of her highest competitive value and her highest commercial value.

Six years, counted from 10 September, returns her to eligibility at roughly age 38.

I sat with that number for a long time.

The core: methylprednisolone is not an anabolic steroid, and that error changes how the whole case reads

This is the point most reports get wrong, and I want to stop here a little longer, because it is not a minor technicality.

Many outlets call methylprednisolone a "steroid." More precisely: it is a synthetic glucocorticoid — a corticosteroid. Not an anabolic-androgenic steroid. In the WADA classification it sits in class S9, and that class is prohibited in-competition only, not out-of-competition. More importantly: it is a Specified Substance — a category recognised as more plausibly linked to inadvertent ingestion or legitimate therapeutic use.

Those three characteristics — glucocorticoid, in-competition only, Specified Substance — together create a completely different handling framework from a typical anabolic case. This substance is the soft half of the case. It is the kind of substance where, with a clean medical file, a valid TUE, and a route and timing of administration that did not fall inside the competition window, there would very likely have been no sanction at all, or a very light one.

Aga said she tested positive because of treatment for a knee injury. That is a medically coherent explanation. Intra-articular corticosteroid injection for a knee is common practice, nothing mysterious. Had the story stopped there, we would have a case of the type "athlete took the right medicine for the right condition but got the procedure wrong" — exactly the kind of case the anti-doping system is designed to handle through a TUE, not through a heavy sanction.

But the story did not stop there.

What decided the Ruti Aga case was not the prohibited substance. It was the document proving the substance was used lawfully — and that document was fake.

AIU determined that the prescription submitted during results management came from a clinic that does not exist. The signatory was a family member with no medical registration. That person claimed to have used an old prescription pad from a former workplace, and the workplace confirmed no one by that name had ever been employed there. This is not an ambiguous case. It is a sealed evidentiary chain, from end to end, with no gap left to argue.

And under the WADA Code, tampering with evidence during results management is an independent, separately sanctionable violation with its own penalty. The baseline is four years.

Add it up: two years for presence of the substance, four years for the tampering, served consecutively rather than concurrently. Six years.

I want to stress this structure because it is often misread. A six-year ban does not mean AIU judged the substance three times more serious than usual. It means there are two separate violations, each with its own penalty range, and the WADA Code requires violations in the same case to be served consecutively. The cover-up was punished more heavily than the underlying act — four years against two.

That is the central governance lesson of this case. Not "don't take prohibited substances." It is this: once you are in the grey zone, the thing you need most is a real medical file, not a good story.

The second core: the Chinese road circuit and the appearance-fee economy

There is a detail in the statement I consider more important than it looks: the triggering race was a half marathon in China.

Not a world championship. Not a Major. A regional road race that invites East African athletes to compete.

This model has existed for over fifteen years and I have followed it long enough to know how it operates. Road races in China — not only the big marathons in Beijing and Shanghai, but hundreds of smaller races across the provinces — need good athletes for a respectable result, for local sponsorship, for photographs in the newspapers. Ethiopian and Kenyan athletes supply exactly that: performance, name value, and an appearance fee that is reasonable against the budget of a second-tier race.

The consequence is a steady flow of world-class athletes moving through races with far less scrutiny than a Major. Not because organisers deliberately look the other way, but because control resources are not proportionate to the number of races and the number of athletes.

The result from that March half marathon will almost certainly be annulled, along with its prize money. That is an economic consequence, not merely a sporting one. For a professional marathoner, prize money from a small race is not a large sum — but it is part of the income structure, and it disappears along with eligibility.

The third core: a replaceable node in a system that is too deep

I want to share something personal here, because it bears directly on how I read this case.

In 2026, when the pandemic shut down every road, I lost my commentary contracts. I could not sit still. I spent nine months rewatching 214 matches from the women's U-20 World Cup between 2026 and 2026, noting every small shift in the role of the female full-back. When I reopened my notes and counted, my biggest finding was that the attacking movement frequency of female full-backs had risen 43% after 2026.

The lesson I took from that project was not the 43%. It was this: when you look at a system long enough, you start to distinguish individual fluctuation from structural shift.

The Ruti Aga case is individual fluctuation. Not structural shift.

Ethiopia produces so many world-class female marathoners that one of them being suspended creates almost no dent in the national results table. The pipeline is so dense that a lost slot is filled within a season. In terms of competitive balance in global women's marathon, this sanction has an effect close to zero.

Ethiopians do not run faster. They have a deeper selection system — and that depth swallows individual losses without leaving a trace.

But there is one thing that is not so easily replaced: brand credibility. The Ethiopian road-running brand has real commercial value — to race organisers, to sponsors, to agents. A case with the detail "fake doctor within the family, clinic does not exist" damages that brand in a way an ordinary positive test does not.

The contrarian angle: the system abandoned her before she abandoned the system

This is where I want to go against the prevailing reading.

The prevailing reading is tidy: an athlete cheats, gets caught, forges documents to escape, gets punished harder. A complete moral story. Nothing more to discuss.

But look at the structure of the forgery. It is not sophisticated. It is not organised. It carries no trace of a systematic doping operation. It is an invented clinic, a relative signing in place of a doctor, an old prescription pad, and a story that could be dismantled by a single verification call.

No one with integrity expertise would do it this way. This is the behaviour of people with no one advising them.

And that is my point. In the East African road-running system, a world-class athlete may have a coach, an agent, someone handling nutrition, someone handling recovery — but very often no one handling legal and medical documentation to international standard. When an athlete like that receives a positive result, the first person she calls is not a lawyer. The first person she calls is a relative.

I have heard the phrase "she was wronged" many times in conversations with female athletes. Now I am retelling it with numbers: two years plus four years, not concurrent, from age 32 to age 38.

Had Aga held a valid TUE, or had she honestly disclosed that she had received a corticosteroid injection for her knee and requested retrospective review, the outcome could have been substantively different. Not necessarily no sanction — but possibly not six years. The difference between those two scenarios is not a difference in morality. It is a difference in access to legal support.

I am not saying this to excuse. Forging medical documents is a serious act and the penalty matches the act. I am saying it to point out that a system that only punishes, without equipping the punished with the tools to defend themselves, is a system operating at less than full capacity.

There is one more point worth stating clearly, because it is often skipped: responsibility does not stop with Aga. The family member who signed the fake prescription may face separate consequences — civil, criminal depending on jurisdiction, and certainly reputational and professional. In forgery cases, AIU and WADA tend to extend investigations to those who assisted. That is the right direction.

A note on how the media will read this case

There are two risks in how this story will be retold.

The first is calling methylprednisolone a "steroid" without distinction. For a general reader, "steroid" evokes anabolic steroids — the class associated with deliberate cheating, muscle gain, performance enhancement. Glucocorticoids are not that. They are anti-inflammatory drugs used in joint-injury treatment in every sports clinic in the world. Conflating the two inflates severity in the wrong place, and at the same time prevents readers from understanding which act was actually punished heavily.

The second risk is over-generalisation. There will be comments along the lines of "Ethiopia again," "African doping systems." The evidence does not support it. This is an individual case, executed clumsily, by people without expertise. There is no sign of an organised programme, no sign of federation involvement, no sign of a network. If there is a systemic problem here, it is a problem of athlete access to medical and legal support — not a problem of national ethics.

About age 38

I want to close the analysis with a simple calculation.

Women's marathon is an event where athletes can sustain elite level into their late thirties. Some still finish near the front at 37, 38, even 39. But those are people who are still racing, still training, still accumulating kilometres inside the system month after month. Six years without racing is not the same as six years racing badly. It is six years without permission to appear in any monitored race, without invitations to any Major, without any appearance fee, without selection to the national team.

A marathoner returning after a six-year break at 38 is not the same person. The physical base can be rebuilt. But position within the system — invitations, agent relationships, ranking placement — has been taken by someone else, and Ethiopia's next cohort is so dense that no slot stays open for more than a season.

Technically, this sanction has an expiry date. In practice, it is a career-ending sentence.

And financially, it ends before the career does: the March result annulled, prize money forfeited, sponsorship contracts potentially terminated under the standard morality clauses in sports contracts.

What I take from this case

Women's marathon does not need pity. It needs to be read with a governance lens.

In seventeen years of following this industry, I have seen many positive tests handled as moral tales: bad actor, wrong act, punishment, done. That reading is tidy, easy to write, easy to share. But it skips exactly the part people need to understand in order to prevent the next case.

The Ruti Aga case does not teach us not to use corticosteroids. It teaches us that in a system where every positive test can become a criminal matter, a medical file is not administrative paperwork — it is part of the competition equipment, as important as a pair of shoes.

And if that system genuinely wants to protect the integrity of the road, it cannot stop at detection and punishment. It has to reach the 24-year-old, the 27-year-old, the 32-year-old sitting in some clinic in Addis Ababa, and say: if you are going to inject your knee, call us first — not your family, afterwards.

Six years is a long sanction. But the more worrying period is the one before it — the period in which a world-class athlete believed the best way to solve a medical problem was to have a relative sign a piece of paper.

That is where the system needs fixing. And that is where I will keep watching.